EPAM Reports Results for Fourth Quarter and Full Year 2024
1. Q4 revenue increased 7.9% to $1.248B with improved EPS performance. Results marked sequential momentum. 2. GAAP operating income improved to 10.9% of revenues with significant acquisition-related gains. EPS growth indicates operational strength. 3. Acquisitions of NEORIS and First Derivative boost global reach and service capabilities. Integration efforts are progressing. 4. 2025 outlook targets 10%-14% revenue growth amid a transition phase and GenAI investment. Future guidance emphasizes sustained market capture.